Cuproptosis-based nanomedicine in cancer metastasis synergistic therapy

Cancer metastasis is a critical indicator of cancer progression and serves as a major cause of cancer-related deaths. Cuproptosis is a novel form of regulated cell death proposed in 2022. Unlike ferroptosis and other known regulated cell deaths (RCDs), cuproptosis has a unique regulatory pathway, an...

Description complète

Détails bibliographiques

Auteurs principaux:	Kan Zhou, Zi-Zhan Li, Yi Liu, Lei-Ming Cao, Han-Yue Luo, Guang-Rui Wang, Kang-Ning Wang, Jinmei Wu, Bing Liu, Zhiyong Song, Lin-Lin Bu
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2026-04-01
Collection:	Acta Pharmaceutica Sinica B
Sujets:	Cuproptosis Cancer metastasis Nanomedicine Immunotherapy Synergistic therapy
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2211383525007336
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!